共 50 条
Energy Expenditure in Upper Gastrointestinal Cancers: a Scoping Review
被引:3
|作者:
Hanna, Lauren
[1
,2
]
Porter, Judi
[1
,2
]
Bauer, Judy
[1
]
Nguo, Kay
[1
]
机构:
[1] Monash Univ, Dept Nutr Dietet & Food, Clayton, Vic, Australia
[2] Deakin Univ, Inst Phys Act & Nutr, Sch Exercise & Nutr Sci, Geelong, Vic, Australia
关键词:
cancer;
upper gastrointestinal cancer;
energy expenditure;
indirect calorimetry;
doubly labeled water;
scoping review;
oncology;
malnutrition;
DOUBLY-LABELED WATER;
NONPROTEIN RESPIRATORY QUOTIENT;
ACUTE-PHASE RESPONSE;
WEIGHT-LOSS;
INDIRECT CALORIMETER;
CACHECTIC PATIENTS;
PANCREATIC-CANCER;
TRANSTHORACIC ESOPHAGECTOMY;
HEPATOCELLULAR-CARCINOMA;
MALNUTRITION PREVALENCE;
D O I:
10.1016/j.advnut.2023.08.002
中图分类号:
R15 [营养卫生、食品卫生];
TS201 [基础科学];
学科分类号:
100403 ;
摘要:
Malnutrition is prevalent in people with upper gastrointestinal (GI) cancers and is associated with shorter survival and poor quality of life. In order to effectively prevent or treat malnutrition, nutrition interventions must ensure appropriate energy provision to meet daily metabolic demands. In practice, the energy needs of people with cancer are frequently estimated from predictive equations which are not cancer-specific and are demonstrated to be inaccurate in this population. The purpose of this scoping review was to synthesize the existing evi-dence regarding energy expenditure in people with upper GI cancer. Three databases (Ovid MEDLINE, Embase via Ovid, CINAHL plus) were systematically searched to identify studies reporting on resting energy expenditure using indirect calorimetry and total energy expenditure using doubly labeled water (DLW) in adults with any stage of upper GI cancer at any point from diagnosis. A total of 57 original research studies involving 2,125 individuals with cancer of the esophagus, stomach, pancreas, biliary tract, or liver were eligible for inclusion. All studies used indirect calorimetry, and one study used DLW to measure energy expenditure, which was reported unadjusted in 42 studies, adjusted for body weight in 32 studies, and adjusted for fat-free mass in 13 studies. Energy expenditure in upper GI cancer was compared with noncancer controls in 19 studies and measured compared with predicted energy expenditure reported in 31 studies. There was het-erogeneity in study design and in reporting of important clinical characteristics between studies. There was also substantial variation in energy expenditure between studies and within and between cancer types. Given this heterogeneity and known inaccuracies of predictive equations in patients with cancer, energy expenditure should be measured in practice wherever feasible. Additional research in cohorts defined by cancer type, stage, and treatment is needed to further characterize energy expenditure in upper GI cancer.
引用
收藏
页码:1307 / 1325
页数:19
相关论文